Aurora Cannabis Inc. (TSX: ACB) says it has increased its stake in competitor CanniMed Therapeutics Inc. (TSX:CMED) by buying 91,800 common shares, taking its total to 657,800 or about 2.7 per cent of the outstanding share pool.
Edmonton-based Aurora says its purchases were made in connection with its offer in November to purchase all of the common shares of CanniMed, a takeover that has been aggressively resisted by the target company.
READ MORE: CanniMed says hostile takeover bid by Aurora weighing on share value
It says the highest price paid for CanniMed shares on Thursday was $23.99 and it has paid an average price of $22.98 per share in the three purchases of its campaign starting last Friday.
![Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.](https://globalnews.ca/wp-content/themes/shaw-globalnews/images/skyline/money123.jpg)
Get weekly money news
Aurora has said it’s allowed to buy up to about five per cent of the Saskatoon-headquartered CanniMed’s stock on the open market.
READ MORE: Aurora Cannabis purchases 116K common shares of CanniMed Therapeutics
On Wednesday, CanniMed urged shareholders not to sell, arguing Aurora’s hostile proposed all-stock deal has had a detrimental effect on its share price.
Watch below: On Nov. 23, 2017, David Boushy filed this report about Aurora Cannabis, a medical marijuana company, expanding with a new grow facility at the Edmonton International Airport.
![Click to play video: 'Medical marijuana company Aurora Cannabis expands to Edmonton airport'](https://i0.wp.com/media.globalnews.ca/videostatic/124/563/2016-12-16T01-51-35.333Z--109.367_848x480_834428483857.jpg?w=1040&quality=70&strip=all)
Comments